{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T03:25:02Z","timestamp":1790220302459,"version":"4.1.0"},"reference-count":55,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001826","name":"Netherlands Organisation for Health Research and Development","doi-asserted-by":"publisher","award":["171002214"],"award-info":[{"award-number":["171002214"]}],"id":[{"id":"10.13039\/501100001826","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.jtha.2025.11.019","type":"journal-article","created":{"date-parts":[[2025,12,13]],"date-time":"2025-12-13T23:36:57Z","timestamp":1765669017000},"page":"1365-1376","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Plasma proteomics does not identify biomarkers of venous thromboembolism recurrence during and after anticoagulation: results from the VISTA study"],"prefix":"10.1016","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-2001-1205","authenticated-orcid":false,"given":"Eva R.","family":"Smit","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geke C.","family":"Poolen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tirsa T.","family":"van Duijl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzanne C.","family":"Cannegieter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana","family":"Mu\u00f1oz Sandoval","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"van der Zwaan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geert-Jan","family":"Geersing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arie J.","family":"Hoogendijk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger E.G.","family":"Schutgens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rolf T.","family":"Urbanus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6970-5496","authenticated-orcid":false,"given":"Maartje","family":"van den Biggelaar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtha.2025.11.019_bib1","article-title":"Long term risk of symptomatic recurrent venous thromboembolism after discontinuation of anticoagulant treatment for first unprovoked venous thromboembolism event: systematic review and meta-analysis","volume":"366","author":"Khan","year":"2019","journal-title":"BMJ"},{"key":"10.1016\/j.jtha.2025.11.019_bib2","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1080\/07853890.2022.2026002","article-title":"Antithrombotic therapy for secondary prevention of unprovoked venous thromboembolism: a systematic review and network meta-analysis of randomized controlled trials","volume":"54","author":"Li","year":"2022","journal-title":"Ann Med"},{"key":"10.1016\/j.jtha.2025.11.019_bib3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta21090","article-title":"Oral anticoagulants for primary prevention, treatment and secondary prevention of venous thromboembolic disease, and for prevention of stroke in atrial fibrillation: systematic review, network meta-analysis and cost-effectiveness analysis","volume":"21","author":"Sterne","year":"2017","journal-title":"Health Technol Assess"},{"key":"10.1016\/j.jtha.2025.11.019_bib4","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.ejvs.2020.09.023","article-title":"Editor\u2019s Choice - European Society for Vascular Surgery (ESVS) 2021 clinical practice guidelines on the management of venous thrombosis","volume":"61","author":"Kakkos","year":"2021","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1016\/j.jtha.2025.11.019_bib5","doi-asserted-by":"crossref","first-page":"4693","DOI":"10.1182\/bloodadvances.2020001830","article-title":"American Society of Hematology 2020 guidelines for management of venous thromboembolism: treatment of deep vein thrombosis and pulmonary embolism","volume":"4","author":"Ortel","year":"2020","journal-title":"Blood Adv"},{"key":"10.1016\/j.jtha.2025.11.019_bib6","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.thromres.2020.12.031","article-title":"Prediction models for recurrence and bleeding in patients with venous thromboembolism: a systematic review and critical appraisal","volume":"199","author":"de Winter","year":"2021","journal-title":"Thromb Res"},{"key":"10.1016\/j.jtha.2025.11.019_bib7","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.ejim.2021.04.004","article-title":"Diagnostic accuracy of D-Dimer testing for recurrent venous thromboembolism: a systematic review with meta-analysis.: VTE recurrence and D-dimer","volume":"89","author":"Di Minno","year":"2021","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.jtha.2025.11.019_bib8","doi-asserted-by":"crossref","first-page":"300","DOI":"10.2165\/00003088-199630040-00003","article-title":"Warfarin withdrawal. Pharmacokinetic-pharmacodynamic considerations","volume":"30","author":"Palareti","year":"1996","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.jtha.2025.11.019_bib9","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.thromres.2010.01.017","article-title":"Influence of anticoagulant therapy with vitamin K antagonists on plasma levels of coagulation factor VIII","volume":"126","author":"Passamonti","year":"2010","journal-title":"Thromb Res"},{"key":"10.1016\/j.jtha.2025.11.019_bib10","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.thromres.2019.03.022","article-title":"Correlation of thromboelastography and thrombin generation assays in warfarin-treated patients","volume":"178","author":"Schmidt","year":"2019","journal-title":"Thromb Res"},{"key":"10.1016\/j.jtha.2025.11.019_bib11","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1111\/jth.13337","article-title":"Risk of recurrent venous thromboembolism after discontinuation of vitamin K antagonist treatment: a nested case-control study","volume":"14","author":"Martinez","year":"2016","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2025.11.019_bib12","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1182\/blood-2009-08-237354","article-title":"Usefulness of repeated D-dimer testing after stopping anticoagulation for a first episode of unprovoked venous thromboembolism: the PROLONG II prospective study","volume":"115","author":"Cosmi","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2025.11.019_bib13","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1111\/bjh.14134","article-title":"Adherence to long-term anticoagulation treatment, what is known and what the future might hold","volume":"174","author":"Abdou","year":"2016","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jtha.2025.11.019_bib14","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.jvssci.2021.08.002","article-title":"Role of von Willebrand factor in venous thromboembolic disease","volume":"3","author":"Michels","year":"2022","journal-title":"JVS Vasc Sci"},{"key":"10.1016\/j.jtha.2025.11.019_bib15","doi-asserted-by":"crossref","first-page":"2771","DOI":"10.3390\/cancers14112771","article-title":"Biomarkers of venous thromboembolism recurrence after discontinuation of low molecular weight heparin treatment for cancer-associated thrombosis (HISPALIS-Study)","volume":"14","author":"Otero","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.jtha.2025.11.019_bib16","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1111\/jth.13113","article-title":"Predictive value of factor VIII levels for recurrent venous thrombosis: results from the MEGA follow-up study","volume":"13","author":"Timp","year":"2015","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2025.11.019_bib17","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.1002652","article-title":"C-reactive protein, immunothrombosis and venous thromboembolism","volume":"13","author":"Dix","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.jtha.2025.11.019_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.rpth.2023.100064","article-title":"Role of factor VIII, IX, and XI in venous thrombosis recurrence risk in adults and children: a systematic review","volume":"7","author":"Bosch","year":"2023","journal-title":"Res Pract Thromb Haemost"},{"key":"10.1016\/j.jtha.2025.11.019_bib19","doi-asserted-by":"crossref","first-page":"3678","DOI":"10.1182\/blood.V95.12.3678.012k45_3678_3682","article-title":"High levels of factor IX increase the risk of venous thrombosis","volume":"95","author":"van Hylckama Vlieg","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2025.11.019_bib20","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1056\/NEJM200003093421004","article-title":"High levels of coagulation factor XI as a risk factor for venous thrombosis","volume":"342","author":"Meijers","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jtha.2025.11.019_bib21","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1111\/bjh.19999","article-title":"Fibrinogen genotypes and their impact on recurrence of venous thromboembolism and family history: a prospective population-based study","volume":"206","author":"Memon","year":"2025","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jtha.2025.11.019_bib22","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1038\/s41598-018-37114-4","article-title":"Faster fibrin clot degradation characterizes patients with central pulmonary embolism at a low risk of recurrent peripheral embolism","volume":"9","author":"Kupis","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.jtha.2025.11.019_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.rpth.2025.102713","article-title":"in collaboration with BEAT-COVID group and Dutch COVID & Thrombosis Coalition. Exploration of the plasma proteomic profile of patients at risk of thromboembolic events","volume":"9","author":"Smit","year":"2025","journal-title":"Res Pract Thromb Haemost"},{"key":"10.1016\/j.jtha.2025.11.019_bib24","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1003142","article-title":"Effect of tailoring anticoagulant treatment duration by applying a recurrence risk prediction model in patients with venous thromboembolism compared to usual care: a randomized controlled trial","volume":"17","author":"Geersing","year":"2020","journal-title":"PLoS Med"},{"key":"10.1016\/j.jtha.2025.11.019_bib25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/biomet\/73.1.1","article-title":"A case-cohort design for epidemiologic cohort studies and disease prevention trials","volume":"73","author":"Prentice","year":"1986","journal-title":"Biometrika"},{"key":"10.1016\/j.jtha.2025.11.019_bib26","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0101176","article-title":"A review of published analyses of case-cohort studies and recommendations for future reporting","volume":"9","author":"Sharp","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.jtha.2025.11.019_bib27","doi-asserted-by":"crossref","first-page":"2284","DOI":"10.1074\/mcp.TIR118.000853","article-title":"A novel LC system embeds analytes in pre-formed gradients for rapid, ultra-robust proteomics","volume":"17","author":"Bache","year":"2018","journal-title":"Mol Cell Proteomics"},{"key":"10.1016\/j.jtha.2025.11.019_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.mcpro.2022.100279","article-title":"Rapid and in-depth coverage of the (phospho-)proteome with deep libraries and optimal window design for dia-PASEF","volume":"21","author":"Skowronek","year":"2022","journal-title":"Mol Cell Proteomics"},{"key":"10.1016\/j.jtha.2025.11.019_bib29","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/s41592-019-0638-x","article-title":"DIA-NN: neural networks and interference correction enable deep proteome coverage in high throughput","volume":"17","author":"Demichev","year":"2020","journal-title":"Nat Methods"},{"key":"10.1016\/j.jtha.2025.11.019_bib30","doi-asserted-by":"crossref","first-page":"888","DOI":"10.3324\/haematol.2011.042663","article-title":"Up-regulation of platelet activation in hemophilia A","volume":"96","author":"van Bladel","year":"2011","journal-title":"Haematologica"},{"key":"10.1016\/j.jtha.2025.11.019_bib31","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0211961","article-title":"Analytical characterization and reference interval of an enzyme-linked immunosorbent assay for active von Willebrand factor","volume":"14","author":"van der Vorm","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.jtha.2025.11.019_bib32","doi-asserted-by":"crossref","first-page":"e47","DOI":"10.1093\/nar\/gkv007","article-title":"limma powers differential expression analyses for RNA-sequencing and microarray studies","volume":"43","author":"Ritchie","year":"2015","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.jtha.2025.11.019_bib33","series-title":"Structural approaches to sequence evolution. Biological and medical physics, biomedical engineering","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/978-3-540-35306-5_10","article-title":"SeqinR 1.0-2: a contributed package to the R Project for statistical computing devoted to biological sequences retrieval and analysis BT - structural approaches to sequence evolution: molecules, networks, populations","author":"Charif","year":"2007"},{"key":"10.1016\/j.jtha.2025.11.019_bib34","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/s43856-025-00856-0","article-title":"Extensive modulation of the circulating blood proteome by hormonal contraceptive use across two population studies","volume":"5","author":"Dordevic","year":"2025","journal-title":"Commun Med (Lond)"},{"key":"10.1016\/j.jtha.2025.11.019_bib35","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1111\/j.1541-0420.2012.01787.x","article-title":"Evaluating the predictive value of biomarkers with stratified case-cohort design","volume":"68","author":"Liu","year":"2012","journal-title":"Biometrics"},{"key":"10.1016\/j.jtha.2025.11.019_bib36","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1016\/j.jhsa.2018.03.013","article-title":"Case-cohort studies: design and applicability to hand surgery","volume":"43","author":"Vojvodic","year":"2018","journal-title":"J Hand Surg Am"},{"key":"10.1016\/j.jtha.2025.11.019_bib37","doi-asserted-by":"crossref","first-page":"5759","DOI":"10.3390\/ijms23105759","article-title":"Vitamin K-dependent protein activation: normal gamma-glutamyl carboxylation and disruption in disease","volume":"23","author":"Berkner","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jtha.2025.11.019_bib38","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/bs.mie.2016.10.015","article-title":"Functional study of the vitamin K cycle enzymes in live cells","volume":"584","author":"Tie","year":"2017","journal-title":"Methods Enzymol"},{"key":"10.1016\/j.jtha.2025.11.019_bib39","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1038\/nsb0695-504","article-title":"Structure of the Ca(2+)-free Gla domain sheds light on membrane binding of blood coagulation proteins","volume":"2","author":"Sunnerhagen","year":"1995","journal-title":"Nat Struct Biol"},{"key":"10.1016\/j.jtha.2025.11.019_bib40","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1084\/jem.154.4.1134","article-title":"Fibronectin and C4-binding protein are selectively bound by aggregated amyloid P component","volume":"154","author":"de Beer","year":"1981","journal-title":"J Exp Med"},{"key":"10.1016\/j.jtha.2025.11.019_bib41","doi-asserted-by":"crossref","first-page":"21749","DOI":"10.1016\/S0021-9258(18)45804-8","article-title":"Independent association of serum amyloid P component, protein S, and complement C4b with complement C4b-binding protein and subsequent association of the complex with membranes","volume":"265","author":"Schwalbe","year":"1990","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jtha.2025.11.019_bib42","doi-asserted-by":"crossref","first-page":"26950","DOI":"10.1074\/jbc.270.45.26950","article-title":"Serum amyloid P component binding to C4b-binding protein","volume":"270","author":"Garc\u00eda de Frutos","year":"1995","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jtha.2025.11.019_bib43","doi-asserted-by":"crossref","DOI":"10.1016\/j.mcpro.2025.101046","article-title":"Structural Insights into Complement Inhibition: visualizing distinct binding modes of C4b-binding protein complexes with C4b and SAP","volume":"24","author":"Kadav\u00e1","year":"2025","journal-title":"Mol Cell Proteomics"},{"key":"10.1016\/j.jtha.2025.11.019_bib44","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1111\/jth.14220","article-title":"Discovery of novel plasma biomarkers for future incident venous thromboembolism by untargeted synchronous precursor selection mass spectrometry proteomics","volume":"16","author":"Jensen","year":"2018","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2025.11.019_bib45","doi-asserted-by":"crossref","first-page":"2357","DOI":"10.1182\/blood.2024027879","article-title":"Molecular determinants of thrombosis recurrence risk across venous thromboembolism subtypes","volume":"146","author":"Munsch","year":"2025","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2025.11.019_bib46","doi-asserted-by":"crossref","first-page":"e59","DOI":"10.1182\/blood-2016-05-711846","article-title":"PDGFB, a new candidate plasma biomarker for venous thromboembolism: results from the VEREMA affinity proteomics study","volume":"128","author":"Bruzelius","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2025.11.019_bib47","doi-asserted-by":"crossref","first-page":"2909","DOI":"10.1182\/bloodadvances.2020003800","article-title":"A targeted proteomics investigation of the obesity paradox in venous thromboembolism","volume":"5","author":"Ten Cate","year":"2021","journal-title":"Blood Adv"},{"key":"10.1016\/j.jtha.2025.11.019_bib48","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1038\/s42004-025-01665-1","article-title":"Current landscape of plasma proteomics from technical innovations to biological insights and biomarker discovery","volume":"8","author":"Kirsher","year":"2025","journal-title":"Commun Chem"},{"key":"10.1016\/j.jtha.2025.11.019_bib49","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1186\/s12974-025-03464-w","article-title":"Impaired membrane lipids in ischemic stroke: a key player in inflammation and thrombosis","volume":"22","author":"Wang","year":"2025","journal-title":"J Neuroinflammation"},{"key":"10.1016\/j.jtha.2025.11.019_bib50","doi-asserted-by":"crossref","first-page":"2494","DOI":"10.1016\/j.jtha.2025.04.017","article-title":"SYMPHONY Consortium. Proteolytic signatures of coagulation identified by plasma peptidomics","volume":"23","author":"Del Castillo Alferez","year":"2025","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2025.11.019_bib51","doi-asserted-by":"crossref","first-page":"2198","DOI":"10.1016\/j.jtha.2025.03.012","article-title":"Discerning specific thrombolytic activities and blood clot degradomes of diverse snake venoms with untargeted peptidomics","volume":"23","author":"Smith","year":"2025","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2025.11.019_bib52","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1055\/s-0037-1615956","article-title":"Factor X levels, polymorphisms in the promoter region of factor X, and the risk of venous thrombosis","volume":"85","author":"de Visser","year":"2001","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jtha.2025.11.019_bib53","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s43556-024-00214-x","article-title":"Post-translational modifications of fibrinogen: implications for clotting, fibrin structure and degradation","volume":"5","author":"Nencini","year":"2024","journal-title":"Mol Biomed"},{"key":"10.1016\/j.jtha.2025.11.019_bib54","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbpa.2023.102313","article-title":"Current insights into the role of citrullination in thrombosis","volume":"75","author":"Green","year":"2023","journal-title":"Curr Opin Chem Biol"},{"key":"10.1016\/j.jtha.2025.11.019_bib55","doi-asserted-by":"crossref","DOI":"10.1016\/j.mcpro.2023.100577","article-title":"MS-based proteomics of body fluids: the end of the beginning","volume":"22","author":"Bader","year":"2023","journal-title":"Mol Cell Proteomics"}],"container-title":["Journal of Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783625008980?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783625008980?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T07:19:02Z","timestamp":1781939942000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538783625008980"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":55,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["S1538783625008980"],"URL":"https:\/\/doi.org\/10.1016\/j.jtha.2025.11.019","relation":{},"ISSN":["1538-7836"],"issn-type":[{"value":"1538-7836","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Plasma proteomics does not identify biomarkers of venous thromboembolism recurrence during and after anticoagulation: results from the VISTA study","name":"articletitle","label":"Article Title"},{"value":"Journal of Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtha.2025.11.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 International Society on Thrombosis and Haemostasis. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}